Aranesp 100? 1 Prefilled Syringe

BRAND NAME: Aranesp (darbepoetin alfa)

ABOUT THE PRODUCT:
Aranesp is a specialized, injectable medication designed to help manage anemia associated with chronic kidney disease and certain types of chemotherapy. By acting as an erythropoiesis-stimulating agent, Aranesp works with your body to support the production of red blood cells. This product is provided in a convenient, single-dose prefilled syringe, streamlining the administration process for those who require consistent, professional-grade support to maintain their health and manage their specific medical needs effectively.

BENEFITS & KEY FEATURES:

• Targeted Support: Specifically engineered to help increase hemoglobin levels in patients dealing with anemia due to chronic kidney disease or specific chemotherapy treatments.
• Convenient Delivery: Comes in a ready-to-use prefilled syringe, ensuring accurate dosing and simplifying the administration process for patients and their caregivers.
• Flexible Options: Suitable for both intravenous or subcutaneous administration, allowing for a versatile approach to treatment based on your healthcare provider’s recommendation.

HOW TO USE SAFELY:

• Directions: Aranesp is administered via injection either intravenously or subcutaneously. The frequency and dosage are determined by your physician based on your specific condition and laboratory results, such as your hemoglobin levels. It is vital to follow the precise schedule provided by your medical team and monitor your hemoglobin levels as instructed to ensure the therapy remains effective and safe.
• Important Tips: Do not shake the prefilled syringe. Always inspect the liquid before use; it should be clear and colorless. If you notice any particles or discoloration, do not use the product. Store the syringes in a refrigerator at the recommended temperature and protect them from direct light. Ensure you have proper training on the injection technique before attempting self-administration.

SAFETY NOTE:
WARNING: ESAs INCREASE THE RISK OF DEATH, MYOCARDIAL INFARCTION, STROKE, VENOUS THROMBOEMBOLISM, THROMBOSIS OF VASCULAR ACCESS AND TUMOR PROGRESSION OR RECURRENCE. Please consult your healthcare professional or physician before use.